Clinical Trials Browser

Approved for marketing × Carcinoma, Medullary × cabozantinib × Clear all

NCT01683110 2013-01-16

Expanded Access of Cabozantinib in Medullary Thyroid Cancer

Approved for marketing

Carcinoma, Medullary